GlassScriptPhysician profile
Harlori Bains
NPI 1497097588
$12,071.67
in general payments reported to CMS, 2019-2025
8 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $38.24 · 2021: $19.22 · 2022: $16.67 · 2024: $137 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,619 · Travel and Lodging: $1,838 · Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,618.75 |
| Travel and Lodging | $1,837.67 |
| Food and Beverage | $401.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11,664.30 | 2025 | |
| Ucb, INC. | $153.66 | 2022-2024 | Nayzilam |
| Emd Serono, INC. | $102.16 | 2019 | |
| Greenwich Biosciences, INC. | $37.87 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $37.55 | 2025 | Ajovy |
| Ironshore Pharmaceuticals INC. | $37.25 | 2019 | |
| Zogenix INC. | $19.59 | 2020 | |
| Boston Scientific Corporation | $19.29 | 2025 | Varithena Administration Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harlori Bains listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.